March 16, 2023
Canadian stem cell research company Hemostemix Inc. has agreed to settle claims made in its suit against a consultant company over clinical data relating to a treatment for an inadequate blood flow condition.
December 16, 2021
Gilead Sciences will ask a Delaware federal judge next week to block the federal government from deposing the pharmaceutical company's CEO in a high-profile patent case over allegations Gilead made billions by selling HIV medications using research funded by taxpayers. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.